Trial Shows New Imaging System May Cut X-Ray Exposure for Liver Cancer Patients

Share this content:
Trial Shows New Imaging System May Cut X-Ray Exposure for Liver Cancer Patients
Trial Shows New Imaging System May Cut X-Ray Exposure for Liver Cancer Patients
Food and Drug Administration in 2013 has the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy (IAT) for liver cancer. 3 at the 100th annual meeting of the Radiological Society of North America in Chicago (abstract #SSM24-02), the researchers described the results of a clinical trial of the imaging system AlluraClarity, made by Philips Healthcare, on 50 patients with liver cancer.
READ FULL ARTICLE From Health News Digest
Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

is free, fast, and customized just for you!




Already a member?

Sign In Now »